Amgen Stock Sees Shifts in Investor Sentiment

NewEdge Advisors LLC has decreased its stake in Amgen Inc. (NASDAQ:AMGN) by 3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.

The institutional investor owned 93,040 shares of the medical research company's stock after selling 2,899 shares during the period.

NewEdge Advisors LLC's holdings in Amgen were worth $33.69 million at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock, including Tower View Wealth Management LLC and Evergreen Advisors LLC, which bought new stakes in the first quarter valued at about $37,000 and $38,000 respectively.